Carnegie Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History

Carnegie Investment Counsel’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$21.3M	Sell	52,413 -3,703	-7%	-$1.5M	0.43%	68
2025 Q1	$24.7M	Sell	56,116 -2,835	-5%	-$1.25M	0.59%	48
2024 Q4	$30.7M	Buy	58,951 +726	+1%	+$378K	0.88%	24
2024 Q3	$36M	Buy	58,225 +3,372	+6%	+$2.09M	1.06%	18
2024 Q2	$30.3M	Buy	54,853 +3,828	+8%	+$2.12M	0.95%	22
2024 Q1	$29.7M	Buy	51,025 +1,584	+3%	+$921K	0.92%	23
2023 Q4	$26.2M	Sell	49,441 -1,792	-3%	-$951K	0.9%	24
2023 Q3	$25.9M	Buy	51,233 +4,954	+11%	+$2.51M	1%	21
2023 Q2	$24.1M	Buy	46,279 +2,911	+7%	+$1.52M	0.89%	25
2023 Q1	$25M	Buy	43,368 +3,914	+10%	+$2.26M	1%	20
2022 Q4	$21.7M	Buy	39,454 +1,008	+3%	+$555K	0.93%	25
2022 Q3	$19.5M	Sell	38,446 -188	-0.5%	-$95.4K	0.93%	23
2022 Q2	$21M	Sell	38,634 -2,071	-5%	-$1.13M	0.95%	24
2022 Q1	$24M	Buy	40,705 +2,071	+5%	+$1.22M	0.88%	30
2021 Q4	$25.8M	Sell	38,634 -696	-2%	-$464K	0.85%	30
2021 Q3	$22.5M	Sell	39,330 -737	-2%	-$421K	0.85%	30
2021 Q2	$20.2M	Buy	40,067 +2,519	+7%	+$1.27M	0.76%	40
2021 Q1	$17.1M	Buy	37,548 +1,004	+3%	+$458K	0.72%	45
2020 Q4	$17M	Buy	36,544 +3,302	+10%	+$1.54M	0.77%	40
2020 Q3	$14.6M	Sell	33,242 -1,279	-4%	-$562K	0.75%	42
2020 Q2	$12.5M	Buy	34,521 +867	+3%	+$313K	0.72%	43
2020 Q1	$9.51M	Buy	33,654 +8,860	+36%	+$2.5M	0.66%	47
2019 Q4	$8.06M	Buy	24,794 +2,881	+13%	+$936K	0.46%	69
2019 Q3	$6.38M	Buy	21,913 +638	+3%	+$186K	0.41%	81
2019 Q2	$6.25M	Buy	21,275 +623	+3%	+$183K	0.41%	75
2019 Q1	$5.65M	Sell	20,652 -113	-0.5%	-$30.9K	0.39%	74
2018 Q4	$4.65M	Buy	20,765 +15,714	+311%	+$3.52M	0.43%	71
2018 Q3	$1.21M	Sell	5,051 -32,130	-86%	-$7.71M	0.1%	180
2018 Q2	$8.19M	Buy	37,181 +4,520	+14%	+$996K	0.62%	50
2018 Q1	$6.91M	Buy	32,661 +5,429	+20%	+$1.15M	0.58%	56
2017 Q4	$5.36M	Buy	+27,232	New	+$5.36M	0.48%	66